KRAS and colorectal carcinoma: HCT116 colorectal carcinoma cells harbor the mutated KRASG13D oncogene (common to 35-45% of CRC patients [33]) and we sought to ascertain whether the cancer cell-induced alteration of CCD-18Co fibroblast gene expression was exclusively KRAS-dependent.